Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 8/20 | 0.47 |
| ▸ | BACE1 | P56817 | 8/20 | 0.47 |
| ▸ | BCHE | P06276 | 5/20 | 0.47 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.45 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.45 |
| ▸ | EBP | Q15125 | 1/20 | 0.45 |
| ▸ | DHCR7 | Q9UBM7 | 1/20 | 0.45 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.43 |
| ▸ | FABP6 | P51161 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26346410 | 0.85 | PRMT6 (0.45) | AKT1ACHEBACE1CARM1PRMT6 | |
| SCHEMBL26346156 | 0.75 | MEN1 (0.58) | ACHEBACE1BCHEHRH4MEN1 | |
| SCHEMBL26348556 | 0.73 | HRH4 (0.55) | AKT1ACHEBACE1BCHECARM1 | |
| SCHEMBL26348679 | 0.73 | HRH4 (0.50) | AKT1ACHEBACE1BCHECARM1 | |
| SCHEMBL14386211 | 0.71 | AKT1 (0.51) | AKT1ACHEBACE1BCHECARM1 | |
| SCHEMBL23579714 | 0.71 | MAPT (0.57) | AKT1ACHEBACE1BCHEEBP | |
| SCHEMBL7841536 | 0.71 | ACHE (0.66) | ACHEBACE1BCHECARM1PRMT6 | |
| SCHEMBL1000971 | 0.71 | AKT1 (0.58) | AKT1ACHEBACE1BCHECARM1 | |
| SCHEMBL26348201 | 0.71 | HRH4 (0.55) | ACHEBACE1BCHEHRH4MEN1 | |
| SCHEMBL18072389 | 0.70 | HRH4 (0.53) | HRH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303512-A1 | MODULATORS OF MYB-MEDIATED TRANSCRIPTION AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303512-A1 | MODULATORS OF MYB-MEDIATED TRANSCRIPTION AND USES THEREOF | MYB, MYBBP1A, MYCBP | AKT1 1861/4885ACHE 4510/4885BACE1 4775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.